Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer.

MLA

Kundranda, Madappa N., et al. “Associations with Other Cancer-Related Biomarkers Might Contribute to Poor Outcomes in RAS-Altered, Younger Patients with Colorectal Cancer.” The Oncologist, vol. 29, no. 9, Sept. 2024, pp. e1228–30. EBSCOhost, https://doi.org/10.1093/oncolo/oyae153.

APA

Kundranda, M. N., Kemkes, A. C., Evans, M. C., Flannery, C. A., Hall, D. W., Hoag, J. R., Therala, N., Thakkar, S. G., & De La O, J.-P. (2024). Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer. The Oncologist, 29(9), e1228–e1230. https://doi.org/10.1093/oncolo/oyae153

Chicago

Kundranda, Madappa N, Ariane C Kemkes, Mark C Evans, Cynthia A Flannery, David W Hall, Jess R Hoag, Nishitha Therala, Snehal G Thakkar, and Jean-Paul De La O. 2024. “Associations with Other Cancer-Related Biomarkers Might Contribute to Poor Outcomes in RAS-Altered, Younger Patients with Colorectal Cancer.” The Oncologist 29 (9): e1228–30. doi:10.1093/oncolo/oyae153.